Literature DB >> 28155133

Parkinson's disease as a multisystem disorder.

Lisa Klingelhoefer1, H Reichmann2.   

Abstract

This article summarises the noteworthy contribution of Professor Jellinger to the understanding of Parkinson's disease (PD) as a disease affecting multiple body- and neurotransmitter-systems. Phosphorylated alpha-synuclein and the formation of Lewy pathology as neuropathological hallmarks of PD seem to spread from the enteric nervous system and the olfactory bulb in a rostrocranial direction to the CNS. Subsequently, a progressive degeneration of the dopaminergic-nigrostriatal system and widespread extranigral pathology affecting different anatomical structures and neurotransmitters are induced causing the various non-motor and motor symptoms of PD.

Entities:  

Keywords:  Alpha-synuclein; NMS; Non-motor symptoms; PD; Parkinson’s disease; Proteinopathy

Mesh:

Year:  2017        PMID: 28155133     DOI: 10.1007/s00702-017-1692-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  74 in total

Review 1.  The neurobiology of sleep: genetics, cellular physiology and subcortical networks.

Authors:  Edward F Pace-Schott; J Allan Hobson
Journal:  Nat Rev Neurosci       Date:  2002-08       Impact factor: 34.870

2.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 4.  The role of protein clearance mechanisms in organismal ageing and age-related diseases.

Authors:  David Vilchez; Isabel Saez; Andrew Dillin
Journal:  Nat Commun       Date:  2014-12-08       Impact factor: 14.919

5.  The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder.

Authors:  Y K Kim; I-Y Yoon; J-M Kim; S-H Jeong; K W Kim; Y-K Shin; B S Kim; S E Kim
Journal:  Eur J Neurol       Date:  2009-11-24       Impact factor: 6.089

6.  Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.

Authors:  Masatoshi Inden; Yoshihisa Kitamura; Hiroki Takeuchi; Takashi Yanagida; Kazuyuki Takata; Yuka Kobayashi; Takashi Taniguchi; Kanji Yoshimoto; Masahiko Kaneko; Yasunobu Okuma; Takahiro Taira; Hiroyoshi Ariga; Shun Shimohama
Journal:  J Neurochem       Date:  2007-06       Impact factor: 5.372

Review 7.  Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.

Authors:  Mark S Forman; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Med       Date:  2004-10       Impact factor: 53.440

Review 8.  General aspects of neurodegeneration.

Authors:  K A Jellinger
Journal:  J Neural Transm Suppl       Date:  2003

9.  Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms.

Authors:  Maria G Cersosimo; Gabriela B Raina; Cristina Pecci; Alejandro Pellene; Cristian R Calandra; Cristiam Gutiérrez; Federico E Micheli; Eduardo E Benarroch
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

10.  Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.

Authors:  Francisco Pan-Montojo; Oleg Anichtchik; Yanina Dening; Lilla Knels; Stefan Pursche; Roland Jung; Sandra Jackson; Gabriele Gille; Maria Grazia Spillantini; Heinz Reichmann; Richard H W Funk
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more
  19 in total

1.  Laryngeal muscle biology in the Pink1-/- rat model of Parkinson disease.

Authors:  Tiffany J Glass; Cynthia A Kelm-Nelson; John A Russell; John C Szot; Jacob M Lake; Nadine P Connor; Michelle R Ciucci
Journal:  J Appl Physiol (1985)       Date:  2019-03-07

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 3.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

Review 4.  Paradoxical Decision-Making: A Framework for Understanding Cognition in Parkinson's Disease.

Authors:  Alessandra Perugini; Jochen Ditterich; Aasef G Shaikh; Barbara J Knowlton; Michele A Basso
Journal:  Trends Neurosci       Date:  2018-05-07       Impact factor: 13.837

5.  Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management.

Authors:  C K Broadfoot; D Abur; J D Hoffmeister; C E Stepp; M R Ciucci
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-11

6.  Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson's disease.

Authors:  Shane V Hegarty; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neuronal Signal       Date:  2018-01-26

Review 7.  Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease.

Authors:  Muthuraman Muthuraman; Nabin Koirala; Dumitru Ciolac; Bogdan Pintea; Martin Glaser; Stanislav Groppa; Gertrúd Tamás; Sergiu Groppa
Journal:  Front Neurol       Date:  2018-08-27       Impact factor: 4.003

8.  α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson's disease.

Authors:  Samanta Mazzetti; Milo J Basellini; Valentina Ferri; Erica Cassani; Emanuele Cereda; Matilde Paolini; Alessandra M Calogero; Carlotta Bolliri; Mara De Leonardis; Giorgio Sacilotto; Roberto Cilia; Graziella Cappelletti; Gianni Pezzoli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

9.  Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.

Authors:  Valeria C Gonçalves; Daniel J L L Pinheiro; Tomás de la Rosa; Antônio-Carlos G de Almeida; Fúlvio A Scorza; Carla A Scorza
Journal:  Nutrients       Date:  2020-05-26       Impact factor: 5.717

10.  A collaborative approach to exercise provision for people with Parkinson's - a feasibility and acceptability study of the PDConnect programme [version 2; peer review: 2 approved].

Authors:  Julie Jones; Lyndsay Alexander; Elizabeth Hancock; Kay Cooper
Journal:  AMRC Open Res       Date:  2021-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.